drugset
drugset / Trial / NCT02857959

One Dose Versus Three Weekly Doses of Benzathine Penicillin G for Patients With Early Syphilis

NCT02857959 ↗

Phase 4 Unknown 150 enrolled Jun Li
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to observe the serological response to 1 or 3 weekly doses of benzathine penicillin G in patients with early syphilis.

Timeline

Start
2016-08
Primary completion
2020-06
Completion
2020-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Benzathine Penicillin G Unknown — —

Indications

syphilis